+629.1%
MRNA vs IRM
+402.9%
+226.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | IRM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.7% | -2.6% | -3.2% |
| 7D | -10.1% | +3.0% | -13.1% | -10.5% |
| 30D | +126.7% | -5.2% | +132.0% | +126.9% |
| 3M | +184.1% | -8.0% | +192.2% | +185.7% |
| 6M | +143.3% | +9.2% | +134.1% | +133.8% |
| YTD | +359.9% | +41.0% | +318.9% | +315.1% |
| 1Y | +454.2% | +23.3% | +430.9% | +416.8% |
| 3Y | +26.0% | +102.8% | -76.9% | +2.8% |
| 5Y | -70.3% | +192.8% | -263.0% | -77.3% |
| All | +629.1% | +402.9% | +226.2% | +435.2% |
Cumulative growth
Daily Returns
Daily percentage return beside IRM.
Daily Out/Under-Performance
Portfolio return minus IRM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded IRM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling